Radiation omission trials: The dust has settled - How to revisit and optimise radiation oncology clinical trial design in smarter ways?
David Krug,
Germany
Radiotherapy has been the focus of many de-escalation trials in oncology. This session gives a critical overview over de-escalation and radiotherapy omission trials as well as the specifics of trial design in this setting, in particular non-inferiority trials. The optimization for future design of trials in this space in regards of patient-relevant endpoints, non-inferiority margins and multi-disciplinary collaboration will be addressed.
Teaching Lecture
Interdisciplinary
Breast